Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

Related Articles by Review for PubMed (Select 17986680)

1.

Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.

Morrato EH, Libby AM, Orton HD, Degruy FV 3rd, Brent DA, Allen R, Valuck RJ.

Am J Psychiatry. 2008 Jan;165(1):42-50. Epub 2007 Nov 6.

PMID:
17986680
3.

[SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].

Tandt H, Audenaert K, van Heeringen C.

Tijdschr Psychiatr. 2009;51(6):387-93. Review. Dutch.

4.

How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?

Hall WD, Lucke J.

Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):941-50. Review.

PMID:
17054562
6.
7.

Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?

Kratochvil CJ, Vitiello B, Walkup J, Emslie G, Waslick BD, Weller EB, Burke WJ, March JS.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):11-24. Review.

PMID:
16553525
8.

Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.

Novak E, Allen PJ.

Pediatr Nurs. 2007 Jan-Feb;33(1):64-70. Review.

PMID:
17411005
9.

Suicide behaviour of patients treated with antidepressants.

Rihmer Z, Gonda X.

Neuropsychopharmacol Hung. 2006 Mar;8(1):13-6. Review.

PMID:
16841560
10.

Antidepressant-induced suicidality: implications for clinical practice.

Reeves RR, Ladner ME.

South Med J. 2009 Jul;102(7):713-8. doi: 10.1097/SMJ.0b013e3181a918bd. Review.

PMID:
19488000
11.

Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.

Giner L, Nichols CM, Zalsman G, Oquendo MA.

Int J Adolesc Med Health. 2005 Jul-Sep;17(3):211-20. Review.

PMID:
16231472
12.

[The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the «black box» warning].

Plener PL, Fegert JM, Kölch MG.

Z Kinder Jugendpsychiatr Psychother. 2012 Nov;40(6):365-71. doi: 10.1024/1422-4917/a000196. Review. German.

PMID:
23109125
13.

Paroxetine.

Tang SW, Helmeste D.

Expert Opin Pharmacother. 2008 Apr;9(5):787-94. doi: 10.1517/14656566.9.5.787 . Review.

PMID:
18345955
14.

Antidepressant-induced suicidality: an update.

Reeves RR, Ladner ME.

CNS Neurosci Ther. 2010 Aug;16(4):227-34. doi: 10.1111/j.1755-5949.2010.00160.x. Epub 2010 Apr 16. Review.

PMID:
20553304
15.

Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story.

Kutcher S, Gardner DM.

Curr Opin Psychiatry. 2008 Jan;21(1):65-9. doi: 10.1097/YCO.0b013e3282f29853. Review.

PMID:
18281842
16.

[Do antidepressants really increase suicide rates in childhood and adolescence?].

Silva H, Martínez JC.

Rev Med Chil. 2007 Sep;135(9):1195-201. Epub 2007 Nov 15. Review. Spanish.

17.

Suicide in children and adolescents.

Greydanus DE, Calles J Jr.

Prim Care. 2007 Jun;34(2):259-73; abstract vi. Review.

PMID:
17666226
18.

The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?

Hesdorffer DC, Kanner AM.

Epilepsia. 2009 May;50(5):978-86. doi: 10.1111/j.1528-1167.2009.02012.x. Review.

PMID:
19496806
19.

New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?

Dudley M, Hadzi-Pavlovic D, Andrews D, Perich T.

Aust N Z J Psychiatry. 2008 Jun;42(6):456-66. doi: 10.1080/00048670802050538. Review.

PMID:
18465372
20.

Managing antidepressant drug therapy in an evolving marketplace.

McCombs J.

Am J Manag Care. 2004 Jul;10(6 Suppl):S173-8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk